Guidance for AstraZeneca (AZN)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2021 | $5.05 – $5.40 | $3.27 | N/A | N/A | = Maintained | Details |
| 2019 | $3.50 – $3.70 | N/A | N/A | N/A | = Maintained | Details |
| 2019 | $3.50 – $3.70 | $3.50 | N/A | N/A | = Maintained | Details |
| 2018 | $3.30 – $3.50 | $1.62 | N/A | N/A | = Maintained | Details |
| Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q2 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2013 | $6.41 | N/A | N/A | N/A | = Maintained | Details |
| 2011 | $7.05 – $7.35 | $7.15 | N/A | N/A |  Raised |
Details |
